Magnetization transfer measurements of exchange between hyperpolarized [1‐13C]pyruvate and [1‐13C]lactate in a murine lymphoma
暂无分享,去创建一个
Rebekah McLaughlin | F. Gallagher | K. Brindle | S. Bohndiek | M. Kettunen | S. Day | D. Hu | T. Witney | R. Mclaughlin | Ferdia A. Gallagher | Mikko I. Kettunen | Sam E. Day | Kevin M. Brindle | De‐en Hu | Timothy H. Witney | Sarah E. Bohndiek
[1] Ferdia A Gallagher,et al. A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment. , 2009, Neoplasia.
[2] D. Spielman,et al. Measuring Michaelis-Menten Kinetics of Hyperpolarized 13C1-Pyruvate Metabolism in a Single Bolus Injection , 2009 .
[3] Craig R. Malloy,et al. Inhibition of carbohydrate oxidation during the first minute of reperfusion after brief ischemia: NMR detection of hyperpolarized 13CO2 and H13CO 3− , 2008, Magnetic resonance in medicine.
[4] Albert P. Chen,et al. Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. , 2008, Cancer research.
[5] G. Radda,et al. In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance , 2008, Proceedings of the National Academy of Sciences.
[6] John Kurhanewicz,et al. Feasibility of using hyperpolarized [1-13C]lactate as a substrate for in vivo metabolic 13C MRSI studies. , 2008, Magnetic resonance imaging.
[7] Pernille R. Jensen,et al. Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate , 2008, Nature.
[8] Kevin Brindle,et al. New approaches for imaging tumour responses to treatment , 2008, Nature Reviews Cancer.
[9] Albert P. Chen,et al. Original contributions Feasibility of using hyperpolarized (1- 13 C)lactate as a substrate for in vivo metabolic 13 C MRSI studies , 2008 .
[10] W. Lam,et al. Kinetic Modeling of Hyperpolaized [ 1-13 C ] Pyruvate Metabolism in Blood , 2008 .
[11] John M Pauly,et al. Hyperpolarized C‐13 spectroscopic imaging of the TRAMP mouse at 3T—Initial experience , 2007, Magnetic resonance in medicine.
[12] Jan Wolber,et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy , 2007, Nature Medicine.
[13] Jun Shen,et al. In vivo 13C saturation transfer effect of the lactate dehydrogenase reaction , 2007, Magnetic resonance in medicine.
[14] Jan Henrik Ardenkjaer-Larsen,et al. Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. , 2006, Cancer research.
[15] Matthew E Merritt,et al. Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI , 2005, Magnetic resonance in medicine.
[16] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[17] J. Ardenkjær-Larsen,et al. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] Detecting early response to cyclophosphamide treatment of RIF‐1 tumors using selective multiple quantum spectroscopy (SelMQC) and dynamic contrast enhanced imaging , 2003, NMR in biomedicine.
[19] Ann Turner,et al. In the Heart , 2001 .
[20] Z. M. Bhujwalla,et al. Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours. , 1998, British Journal of Cancer.
[21] J A Romijn,et al. Lactate-pyruvate interconversion in blood: implications for in vivo tracer studies. , 1994, The American journal of physiology.
[22] J R Griffiths,et al. An assessment of 31P MRS as a method of measuring pH in rat tumours , 1992, NMR in biomedicine.
[23] Y. Pocker,et al. A comparative study of the enolization of pyruvate and the reversible dehydration of pyruvate hydrate , 1992 .
[24] Kevin M. Brindle,et al. NMR methods for measuring enzyme kinetics in vivo , 1988 .
[25] L. Sauer,et al. In vivo lactate production and utilization by Jensen sarcoma and Morris hepatoma 7288CTC. , 1986, Cancer research.
[26] L. Sauer,et al. Regulation of lactate production and utilization in rat tumors in vivo. , 1985, The Journal of biological chemistry.
[27] I. Campbell,et al. A p.m.r. isotope-exchange method for studying the kinetic properties of dehydrogenases in intact cells. , 1982, The Biochemical journal.
[28] H A Krebs,et al. Cytosolic phosphorylation potential. , 1979, The Journal of biological chemistry.
[29] K. Laidler,et al. Molecular kinetics of beef heart lactate dehydrogenase. , 1974, Biochemistry.
[30] P. Boyer,et al. EQUILIBRIUM REACTION RATES AND THE MECHANISMS OF BOVINE HEART AND RABBIT MUSCLE LACTATE DEHYDROGENASES. , 1964, The Journal of biological chemistry.
[31] H. Mcconnell. Reaction Rates by Nuclear Magnetic Resonance , 1958 .